KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Boston Scientific (BSX) Gross Margin (2016 - 2025)

Boston Scientific (BSX) has disclosed Gross Margin for 17 consecutive years, with 69.6% as the latest value for Q4 2025.

  • Quarterly Gross Margin rose 174.0% to 69.6% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 69.02% through Dec 2025, up 40.0% year-over-year, with the annual reading at 69.01% for FY2025, 41.0% up from the prior year.
  • Gross Margin hit 69.6% in Q4 2025 for Boston Scientific, roughly flat from 69.93% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 70.63% in Q2 2023 to a low of 67.51% in Q1 2021.
  • Historically, Gross Margin has averaged 68.94% across 5 years, with a median of 68.88% in 2021.
  • Biggest five-year swings in Gross Margin: surged 878bps in 2021 and later crashed -152bps in 2025.
  • Year by year, Gross Margin stood at 68.92% in 2021, then decreased by 0bps to 68.85% in 2022, then grew by 1bps to 69.23% in 2023, then decreased by -2bps to 67.86% in 2024, then grew by 3bps to 69.6% in 2025.
  • Business Quant data shows Gross Margin for BSX at 69.6% in Q4 2025, 69.93% in Q3 2025, and 67.65% in Q2 2025.